ConductScience.org, home

Paper33765691

Endothelin receptor antagonists for pulmonary arterial hypertension.

Liu C and 4 others. Cochrane Database Syst Rev, 2021. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Endothelin receptor antagonists for pulmonary arterial hypertension. Papers, record 33765691. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33765691

Download JSON
Disease
systemic sclerosis114 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Endothelin receptor antagonists for pulmonary arterial hypertension.
PubMed
Journal
Cochrane Database Syst Rev
PubMed
Year
2021
PubMed
Publication types
Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
2.19
iCite
Revised in PubMed
2024-08-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu CChao
2Chen JJunmin
3Gao YYanqiu
4Deng BBao
5Liu KKunshen

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
Endothelin Receptor AntagonistsMajor topic
Hypertension, PulmonaryMajor topic
Bias
Humans
Phosphodiesterase 5 Inhibitors
Randomized Controlled Trials as Topic
Walk Test

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00070590Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With SclerodermaDerived from the trialYesClinicalTrials.gov
NCT00077584Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With SclerodermaDerived from the trialYesClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of23450552Endothelin receptor antagonists for pulmonary arterial hypertension.https://conductscience.org/library/papers/23450552

Source PubMed

Download CSV of comments and corrections

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118831711Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.Clin Sci (Lond)2009https://conductscience.org/library/papers/18831711PubMed
224524605[Efficacy of endothelin receptor antagonist bosentan on the long-term prognosis in patients after Fontan operation].Zhonghua Xin Xue Guan Bing Za Zhi2013https://conductscience.org/library/papers/24524605PubMed
320581169Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy.Am J Respir Crit Care Med2010https://conductscience.org/library/papers/20581169PubMed
415593188Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.Arthritis Rheum2004https://conductscience.org/library/papers/15593188PubMed
512706935Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.J Am Coll Cardiol2003https://conductscience.org/library/papers/12706935PubMed
616793845Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.Ann Rheum Dis2006https://conductscience.org/library/papers/16793845PubMed
720506355Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis.Arthritis Rheum2010https://conductscience.org/library/papers/20506355PubMed
821256048Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension.J Heart Lung Transplant2011https://conductscience.org/library/papers/21256048PubMed
922723290The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension.Am J Respir Crit Care Med2012https://conductscience.org/library/papers/22723290PubMed
1024293470Pathogenesis of pulmonary arterial hypertension: lessons from cancer.Eur Respir Rev2013https://conductscience.org/library/papers/24293470PubMed
1119095129
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
J Am Coll Cardiol2008https://conductscience.org/library/papers/19095129PubMed
1225405182The role of endothelin-1 in pulmonary arterial hypertension.Glob Cardiol Sci Pract2014https://conductscience.org/library/papers/25405182PubMed
139727772Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.Eur Respir J1998https://conductscience.org/library/papers/9727772PubMed
1416982941Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.Circulation2006https://conductscience.org/library/papers/16982941PubMed
1528233631Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis.Int J Cardiol2017https://conductscience.org/library/papers/28233631PubMed
1615601804Comparative investigation of the pharmacokinetics of bosentan in Caucasian and Japanese healthy subjects.J Clin Pharmacol2005https://conductscience.org/library/papers/15601804PubMed
1730957635Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH).Pulm Circ2019https://conductscience.org/library/papers/30957635PubMed
1823523254Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.J Cardiothorac Vasc Anesth2013https://conductscience.org/library/papers/23523254PubMed
199692778Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects.Br J Pharmacol1998https://conductscience.org/library/papers/9692778PubMed
2018572079Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial.Lancet2008https://conductscience.org/library/papers/18572079PubMed

See all 115 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42948525
Machine learning, molecular docking, and experimental validation identify shared molecular signatures between idiopathic pulmonary arterial hypertension and malignant pleural mesothelioma: a retrospective study.
Front Genet2026https://conductscience.org/library/papers/42948525PubMed
42172221Exploratory research on drugs after lung surgery based on real-world data from the FDA adverse event reporting system database.PLoS One2026https://conductscience.org/library/papers/42172221PubMed
41363010Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension.Hypertension2026https://conductscience.org/library/papers/41363010PubMed
41309270Impact of positive airway pressure therapy on pulmonary arterial pressures in obstructive sleep apnoea or obesity hypoventilation syndrome: a systematic review and meta-analysis.Eur Respir J2026https://conductscience.org/library/papers/41309270PubMed
41031504Endothelin: A Potential Universal Systemic Biomarker.Curr Med Chem2026https://conductscience.org/library/papers/41031504PubMed
40757552Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension.Cochrane Database Syst Rev2025https://conductscience.org/library/papers/40757552PubMed
40724982Pulmonary Embolism in Acute Ischaemic Stroke: Evolving Evidence, Diagnostic Challenges, and a Novel Thromboinflammatory Axis Hypothesis.Int J Mol Sci2025https://conductscience.org/library/papers/40724982PubMed
40601167Endothelin Receptor Antagonists for the Treatment of Hypertension: Recent Data from Clinical Trials and Implementation Approach.Curr Cardiol Rep2025https://conductscience.org/library/papers/40601167PubMed
40358683Repurposing of modafinil as an anti-inflammatory drug: a systematic review of experimental studies.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40358683PubMed
39995630Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension.J Pharm Technol2025https://conductscience.org/library/papers/39995630PubMed
39897541Shear stress unveils patient-specific transcriptional signatures in PAH: Towards personalized molecular diagnostics.Theranostics2025https://conductscience.org/library/papers/39897541PubMed
398661132025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation2025https://conductscience.org/library/papers/39866113PubMed
39684535Complement Immune System in Pulmonary Hypertension-Cooperating Roles of Circadian Rhythmicity in Complement-Mediated Vascular Pathology.Int J Mol Sci2024https://conductscience.org/library/papers/39684535PubMed
39075075Structural basis of antagonist selectivity in endothelin receptors.Cell Discov2024https://conductscience.org/library/papers/39075075PubMed
39023895Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan.JAMA Netw Open2024https://conductscience.org/library/papers/39023895PubMed
38555425Novel insights and new therapeutic potentials for macrophages in pulmonary hypertension.Respir Res2024https://conductscience.org/library/papers/38555425PubMed
38366267Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.Eur J Pediatr2024https://conductscience.org/library/papers/38366267PubMed
382649142024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.Circulation2024https://conductscience.org/library/papers/38264914PubMed
38195688The underlying mechanisms of DNA methylation in high salt memory in hypertensive vascular disease.Sci Rep2024https://conductscience.org/library/papers/38195688PubMed
37443671Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure?Diagnostics (Basel)2023https://conductscience.org/library/papers/37443671PubMed

See all 27 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PDE5A8654PubTator's text mininghttps://conductscience.org/library/genes/8654

Source NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
BOSENTANCHEMBL957Derived from the trial2https://conductscience.org/library/drugs/CHEMBL957

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33765691

GET https://conductscience.org/api/papers/v1/33765691/references?page=2